For instance, increased concentrations of peripheral biomarkers of inflammation, such as C-reactive protein (CRP) and interleukin-6 (IL-6), are associated with future symptoms of depression, and decrease with antidepressant treatment.1 This evidence concerns the gene CRP and depressive symptom measurement.